Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole in resistant OCD
NCT06611592Phase 2Recruiting
- Sponsor
- Clinical Academic Center
- Start
- Aug 2024
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of pramipexole in obsessive compulsive disorder (OCD), sponsored by Clinical Academic Center. Started Aug 2024; status: recruiting.
02
Drugs
pramipexole
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT06611592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06611592.